2024-02-22 19:34:06 ET
Dynavax Technologies Corporation (DVAX)
Q4 2023 Earnings Conference Call
February 22, 2024 04:30 PM ET
Company Participants
Paul Cox - Vice President, Investor Relations & Corporate Communications
Ryan Spencer - Chief Executive Officer
Donn Casale - Chief Commercial Officer
Rob Janssen - Chief Medical Officer
Kelly MacDonald - Chief Financial Officer
Conference Call Participants
Matthew Phipps - William Blair
Jonathan Miller - Evercore ISI
Paul Choi - Goldman Sachs
Ernesto Rodriguez-Dumont - Cowen
Roy Buchanan - Citizens JMP
Presentation
Operator
Good day ladies and gentlemen and welcome to the Dynavax Technologies' Fourth Quarter and Full Year 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At the end of the company's prepared remarks, we'll open the call for questions and provide specific instructions at that time.
I would now like to turn the call over to Paul Cox, Vice President, Investor Relations and Corporate Communications. You may begin.
Paul Cox
Thank you for participating in today's call. Joining me from Dynavax are Ryan Spencer, Chief Executive Officer; Donn Casale, Chief Commercial Officer; Rob Janssen, Chief Medical Officer; and Kelly MacDonald, Chief Financial Officer.
Earlier today, Dynavax released financial results for the fourth quarter and full year ended December 31st, 2023. Copies of the press release and a supplementary slide presentation are available on Dynavax's website....
Read the full article on Seeking Alpha
For further details see:
Dynavax Technologies Corporation (DVAX) Q4 2023 Earnings Call Transcript